Robot assisted large intestine surgery and intravenous fluid management and it’s effect on length of hospital stay

Effects of Zero-balance fluid therapy in Robotic assisted colorectal surgeries on duration of hospital stay and peri-operative complications: A randomized controlled trial.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023421

Enrollment

Registered

2020-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C20- Malignant neoplasm of rectum Health Condition 2: K55-K64- Other diseases of intestines Health Condition 3: C19- Malignant neoplasm of rectosigmoidjunction Health Condition 4: C18- Malignant neoplasm of colon Health Condition 5: K00-K95- Diseases of the digestive system

Interventions

Intervention1: Zero balance fluid therapy: No fasting and third space replacement.All patients are allowed to take clear water till 2 hours before surgery. Maintenance: 1-4ml/kg/hour If blood loss exc

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for elective robotic assisted colorectal surgery, aged >18 years <65 years , ASA PS I II, III will be included in the study after obtaining written informed consent.

Exclusion criteria

Exclusion criteria: 1. Congestive heart failure, stage NYHA IV 2. Chronic obstructive pulmonary disease stage GOLD IV i.e FEV1% predicted 3. CKD IIIb/ IV/V 4. Sepsis, coagulopathies. 5. Malnutrition- body mass index 6. BMI >40, 7. alcohol intake > 5 drinks/day, 8. Pregnant or lactating women 9. Patients who had contraindications for the use of hydroxylethyl starch (HES) 10. Decompensated liver disease

Design outcomes

Primary

Measure	Time frame
duration of hospital stay in robotic assisted colorectal surgeries.Timepoint: around the Time of discharge using readiness for discharge criteria	—

Secondary

Measure	Time frame
30 day mortality rateTimepoint: Post operative day 30;Intraoperative oliguria or anuriaTimepoint: Till end of surgery;Readmission to ICUTimepoint: Till Post operative day 30;Readmission to hospitalTimepoint: Post operative day 30;Postoperative adverse events by using CD classificationTimepoint: Till the patient stays in the hospital	—

Countries

India

Contacts

Public ContactAswini Kuberan

JIPMER

ashdoctor.kuberan@gmail.com9914017949

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026